| 000 | 01585 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513205706.0 | ||
| 264 | 0 | _c20000606 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0928-4257 | ||
| 024 | 7 |
_a10.1016/s0928-4257(99)00102-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurghardt, B | |
| 245 | 0 | 0 |
_aInhibitory effect of a long-acting somatostatin analogue on EGF-stimulated cell proliferation in Capan-2 cells. _h[electronic resource] |
| 260 |
_bJournal of physiology, Paris _c |
||
| 300 |
_a57-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCholecystokinin _xpharmacology |
| 650 | 0 | 4 |
_aDNA _xbiosynthesis |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOctreotide _xpharmacology |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aProtein Isoforms _xmetabolism |
| 650 | 0 | 4 | _aReceptor, Cholecystokinin A |
| 650 | 0 | 4 | _aReceptor, Cholecystokinin B |
| 650 | 0 | 4 |
_aReceptors, Cholecystokinin _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Somatostatin _xmetabolism |
| 650 | 0 | 4 |
_aThymidine _xmetabolism |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xpathology |
| 700 | 1 | _aBarabás, K | |
| 700 | 1 | _aMarcsek, Z | |
| 700 | 1 | _aFlautner, L | |
| 700 | 1 | _aGress, T M | |
| 700 | 1 | _aVarga, G | |
| 773 | 0 |
_tJournal of physiology, Paris _gvol. 94 _gno. 1 _gp. 57-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0928-4257(99)00102-3 _zAvailable from publisher's website |
| 999 |
_c10714918 _d10714918 |
||